215 related articles for article (PubMed ID: 29471115)
1. Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines.
Bräuninger A; Blau W; Kunze K; Desch AK; Brobeil A; Tur MK; Etschmann B; Günther U; Körholz D; Schliesser G; Käbisch A; Kiehl M; Rummel M; Gattenlöhner S
J Mol Diagn; 2018 May; 20(3):344-354. PubMed ID: 29471115
[TBL] [Abstract][Full Text] [Related]
2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
3. Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.
Bartels S; Schipper E; Hasemeier B; Kreipe H; Lehmann U
Oncotarget; 2016 May; 7(21):30084-93. PubMed ID: 27029036
[TBL] [Abstract][Full Text] [Related]
4. The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
Duncavage EJ; Tandon B
Int J Lab Hematol; 2015 May; 37 Suppl 1():115-21. PubMed ID: 25976969
[TBL] [Abstract][Full Text] [Related]
5. Early Detection of Myelodysplastic Syndrome/Leukemia-associated Mutations Using NGS Is Critical in Treating Aplastic Anemia.
Li X; Wu YH; Cai SS; Li WM; You Y; Zhang M
Curr Med Sci; 2019 Apr; 39(2):217-221. PubMed ID: 31016513
[TBL] [Abstract][Full Text] [Related]
6. Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.
Sakr R; Renneville A; Saada V; Cotteret S; Martin JE; Droin N; Selimoglu-Buet D; Besse B; Hollebecque A; Marzac C; Pasquier F; Micol JB; De Botton S; Mir O; Solary E; Willekens C
Leuk Lymphoma; 2018 Jul; 59(7):1742-1745. PubMed ID: 29115897
[No Abstract] [Full Text] [Related]
7. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
[TBL] [Abstract][Full Text] [Related]
8. Detection of an activated JAK3 variant and a Xq26.3 microdeletion causing loss of PHF6 and miR-424 expression in myelodysplastic syndromes by combined targeted next generation sequencing and SNP array analysis.
Kunze K; Gamerdinger U; Leßig-Owlanj J; Sorokina M; Brobeil A; Tur MK; Blau W; Burchardt A; Käbisch A; Schliesser G; Kiehl M; Rosenwald A; Rummel M; Grimminger F; Hain T; Chakraborty T; Bräuninger A; Gattenlöhner S
Pathol Res Pract; 2014 Jun; 210(6):369-76. PubMed ID: 24674452
[TBL] [Abstract][Full Text] [Related]
9. Where Does Morphology Fit in Myelodysplastic Syndrome Diagnosis in the Era of Molecular Testing?
Giagounidis A; Haase S
Hematol Oncol Clin North Am; 2020 Apr; 34(2):321-331. PubMed ID: 32089213
[TBL] [Abstract][Full Text] [Related]
10. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
[TBL] [Abstract][Full Text] [Related]
11. Genetic and Clinical Studies of Patients With Increased Multinucleated Megakaryocytes in Bone Marrow as an Isolated Finding: A Diagnostic Pitfall for Myelodysplastic Syndrome.
Zheng G; He R; Reichard KK; Peterson JF; Olteanu H; Oliveira JL; Rangan A; Chen D; Shi M
Am J Surg Pathol; 2021 Nov; 45(11):1534-1540. PubMed ID: 33999554
[TBL] [Abstract][Full Text] [Related]
12. High concordance of clone detection between peripheral blood and bone marrow by targeted next-generation sequencing-A pilot study in patients with MDS.
Loacker L; Petzer V; Bachmann S; Griesmacher A; Wolf D; Stauder R
Br J Haematol; 2023 Aug; 202(3):e16-e19. PubMed ID: 37263977
[No Abstract] [Full Text] [Related]
13. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity.
Zhang MY; Keel SB; Walsh T; Lee MK; Gulsuner S; Watts AC; Pritchard CC; Salipante SJ; Jeng MR; Hofmann I; Williams DA; Fleming MD; Abkowitz JL; King MC; Shimamura A
Haematologica; 2015 Jan; 100(1):42-8. PubMed ID: 25239263
[TBL] [Abstract][Full Text] [Related]
14. Next-Generation Gene Sequencing Differentiates Hypoplastic Myelodysplastic Syndrome from Aplastic Anemia.
Lew JL; Fenderson JL; Carmichael MG
Hawaii J Med Public Health; 2017 Nov; 76(11 Suppl 2):10-12. PubMed ID: 29164009
[TBL] [Abstract][Full Text] [Related]
15. Inspecting Targeted Deep Sequencing of Whole Genome Amplified DNA Versus Fresh DNA for Somatic Mutation Detection: A Genetic Study in Myelodysplastic Syndrome Patients.
Palomo L; Fuster-Tormo F; Alvira D; Ademà V; Armengol MP; Gómez-Marzo P; de Haro N; Mallo M; Xicoy B; Zamora L; Solé F
Biopreserv Biobank; 2017 Aug; 15(4):360-365. PubMed ID: 28586236
[TBL] [Abstract][Full Text] [Related]
16. Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing.
Andrulis M; Capper D; Luft T; Hartmann C; Zentgraf H; von Deimling A
Leuk Res; 2010 Aug; 34(8):1091-3. PubMed ID: 20227112
[TBL] [Abstract][Full Text] [Related]
17. Getting personal with myelodysplastic syndromes: is now the right time?
Chokr N; Pine AB; Bewersdorf JP; Shallis RM; Stahl M; Zeidan AM
Expert Rev Hematol; 2019 Apr; 12(4):215-224. PubMed ID: 30977414
[TBL] [Abstract][Full Text] [Related]
18. Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes.
Martin R; Acha P; Ganster C; Palomo L; Dierks S; Fuster-Tormo F; Mallo M; Ademà V; Gómez-Marzo P; De Haro N; Solanes N; Zamora L; Xicoy B; Shirneshan K; Flach J; Braulke F; Schanz J; Kominowski A; Stromburg M; Brockmann A; Trümper L; Solé F; Haase D
Am J Hematol; 2018 Jun; 93(6):E152-E154. PubMed ID: 29575088
[No Abstract] [Full Text] [Related]
19. Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes.
Guo Y; Bosompem A; Mohan S; Erdogan B; Ye F; Vickers KC; Sheng Q; Zhao S; Li CI; Su PF; Jagasia M; Strickland SA; Griffiths EA; Kim AS
BMC Genomics; 2015 Sep; 16():727. PubMed ID: 26400237
[TBL] [Abstract][Full Text] [Related]
20. What role can next-generation sequencing play in myelodysplastic syndrome care?
Bonadies N; Bacher VU
Expert Rev Hematol; 2019 Jun; 12(6):379-382. PubMed ID: 31063400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
